Animal models in vaccinology: state of the art and future perspectives for an animal-free approach.
Autor: | Chiarot E; GSK, Siena, Italy. Electronic address: emiliano.x.chiarot@gsk.com., Pizza M; GSK, Siena, Italy. Electronic address: mariagrazia.x.pizza@gsk.com. |
---|---|
Jazyk: | angličtina |
Zdroj: | Current opinion in microbiology [Curr Opin Microbiol] 2022 Apr; Vol. 66, pp. 46-55. Date of Electronic Publication: 2021 Dec 22. |
DOI: | 10.1016/j.mib.2021.11.014 |
Abstrakt: | Vaccine discovery and development is mainly driven by studies on immunogenicity and safety based on the appropriate animal models. In this review we will describe the importance of animal models in vaccinology, from research and development to pre-licensure and post-licensure commitments with particular emphasis on the advantages and limitations of each animal species. Finally, we will describe the most modern technologies, the new in vitro and ex vivo models and the new advances in the field which may drive into a new era of 'animal free' vaccinology. (Copyright © 2021 Elsevier Ltd. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |